Form 8-K - Current report:
SEC Accession No. 0001193125-24-042131
Filing Date
2024-02-22
Accepted
2024-02-22 08:30:32
Documents
14
Period of Report
2024-02-21
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d784569d8k.htm   iXBRL 8-K 31574
  Complete submission text file 0001193125-24-042131.txt   156888

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA amam-20240221.xsd EX-101.SCH 2844
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE amam-20240221_lab.xml EX-101.LAB 17978
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amam-20240221_pre.xml EX-101.PRE 11254
15 EXTRACTED XBRL INSTANCE DOCUMENT d784569d8k_htm.xml XML 3639
Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 875-2400
Ambrx Biopharma, Inc. (Filer) CIK: 0001990550 (see all company filings)

EIN.: 932892120 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56600 | Film No.: 24662412
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)